A critical discovery in cancer research is emerging with the use of nanobodies to reactivate damaged p53. This essential cancer inhibitor protein is frequently disabled in various forms of tumors, leading uncontrolled https://socialmediastore.net/story23139663/vhh-fragments-restore-p53-a-promising-hope-for-tumor-therapy